Post-cardiac transplantation gout: incidence of therapeutic complications

A E Wluka1, P F Ryan, A M Miller

  • 1Rheumatology Unit, Alfred Hospital, Melbourne, Australia. anita.wluka@med.monash.edu.au

Insights

Gout treatment in cardiac transplant patients carries significant risks, including serious complications like pancytopenia and neuromyopathy. Careful management is crucial for patient health and immunosuppression effectiveness.

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Gout is a common comorbidity in patients with end-stage renal disease.
  • Cardiac transplantation is a life-saving procedure for eligible patients.
  • Management of gout in transplant recipients requires careful consideration of potential drug interactions and side effects.

Purpose of the Study:

  • To investigate the clinical outcomes and complications associated with gout treatment in patients who have undergone cardiac transplantation.
  • To assess the impact of gout pharmacotherapy on the health and immunosuppressive regimens of cardiac transplant recipients.

Main Methods:

  • A retrospective audit was conducted on cardiac transplant recipients at Alfred Hospital before August 1998.
  • Patient data, including pre-transplant and post-transplant gout diagnoses and treatments, were analyzed.
  • Complications arising from gout medications such as allopurinol, colchicine, and NSAIDs were documented.

Main Results:

  • Out of 225 patients, 19% had pre-transplant gout, and 19% experienced recurring gout post-transplantation. 23 patients developed de novo gout.
  • Allopurinol use led to pancytopenia in 6 out of 24 patients, necessitating hospitalization and changes in immunosuppression.
  • Colchicine treatment resulted in neuromyopathy in 5 out of 32 patients, with impaired renal function, diuretic use, and hypertension being more prevalent in this group.
  • Non-steroidal anti-inflammatory agents (NSAIDs) caused severe gastrointestinal complications in one patient, leading to chronic renal failure.

Conclusions:

  • Cardiac transplant recipients are at a high risk of developing serious therapeutic complications when treated for gout.
  • Gout treatment significantly impacts the overall care, health status, and immunosuppressive management of these vulnerable patients.
  • Close monitoring and individualized treatment strategies are essential for managing gout in cardiac transplant recipients to mitigate risks.
Abstract

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...